The Effects of Sotagliflozin in Type 1 Diabetes on Clinical Markers Associated With Cardiorenal Protection: An Exploratory Analysis of inTandem3
Vikas S. Sridhar, Hiddo J.L. Heerspink, Michael J. Davies, Phillip Banks, Manon Girard, Satish K. Garg, David Z.I. Cherney
Topics & Concepts
MedicineDiabetes mellitusType 1 diabetesCardiorenal syndromeType 2 diabetesIntensive care medicineInternal medicineEndocrinologyHeart failureDiabetes Treatment and ManagementDiabetes Management and ResearchPancreatic function and diabetes